Redpoint Bio Corp. (RPBC.OB) Highlights Achievements and Q1 Performance
Redpoint Bio Corp. (OTCBB: RPBC) engages in the development of ingredients to enhance the taste of pharmaceutical, food and beverage products. Today the company announced financial and operational results for the first quarter ended March 31, 2008, as well as recent highlights. The company posted revenues of $0.9 million, which includes research and development collaboration with Givaudan, effective March 2007. The performance was also affected by the company’s research and technology development agreement with The Coca-Cola Company, signed December 2007. For the first quarter of 2007, the company reported revenues of $41,000. “We are pleased with our operational progress during…